<DOC>
	<DOCNO>NCT01779557</DOCNO>
	<brief_summary>This study evaluate effectiveness safety Huaren Peritoneal Dialysate Baxter Peritoneal Dialysate , investigate proper dialysis dose Chinese CAPD patient .</brief_summary>
	<brief_title>Safety Effectiveness Evaluation Two Kinds Peritoneal Dialysate</brief_title>
	<detailed_description>This study prospective , randomize , parallel , control , multi-center clinical study Huaren Peritoneal Dialysate Baxter Peritoneal Dialysate.It aim investigate proper dialysis dose Chinese CAPD patients.At time , evaluate effectiveness safety Chinese product Huaren Peritoneal Dialysate peritoneal dialysis product Baxter Peritoneal Dialysate .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Dialysis Solutions</mesh_term>
	<criteria>Age ≥18 , male female Patients end stage renal disease Dialysis mode : CAPD Dialysis duration : ≥30 day ≤6 month Be capable implement home dialysis Diabetic nephropathy , 3ml/min≤ residual renal GFR ≤15ml/min ; renal disease , 3ml/min≤ residual renal GFR ≤10ml/min Sign write informed consent Acute renal failure Planing receive kidney transplantation 2 year Hemodialysis Exit site infection tunnel infection Presenting 2/3 following : a. abdominal pain , turbid ascites , without fever ; b. drainage fluid WBC＞100×106/L , neutrophil ratio＞50 % ; c.culture positive/ Gram stain positive drainage fluid ; AntiHIV positive Allergic component dialysate Active , residual malignant tumor , systemic infection , liver cirrhosis , severe congestive heart failure , anemia（Hb &lt; 80g/L） , malnutrition（Serum Alb &lt; 28g/L） , refractory hypertension Identified peritoneal high transportation peritoneal equilibration test ( PET ) Extreme body shape ( height &gt; 185cm height &lt; 145cm ) , obesity ( BMI ≥ 33kg/m2 ) Poor compliance Pregnant lactating , woman childbearing age agree use effective contraceptive measure trial Has history alcoholism drug abuse ( define illegal drug ) Any circumstance patient believe unsuitable trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>CAPD</keyword>
	<keyword>efficacy</keyword>
	<keyword>safety</keyword>
	<keyword>survival rate</keyword>
</DOC>